Print Page | Sign In | Join Today
News & Press: Industry News

VA Catalyst Announces $2.7M in Grants to Fund Collaborative Bioscience Research

Monday, July 16, 2018  
Share |
The Virginia Biosciences Health Research Corporation (VBHRC), now known as Virginia Catalyst, announced that it has awarded a total of $2.7 million to six life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with nearly $5.7 million in matching funds from partner companies, were awarded as Round 8 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet medical needs, and that can create high-paying jobs in the Commonwealth.

“With this eighth round of funding, Virginia Catalyst has now awarded $15.7 million to Virginia companies and universities working on incredible technologies that can benefit the whole of society,” said Mike Grisham, CEO of Virginia Catalyst. “These six projects embody Virginia Catalyst’s core mission in that not only can they help citizens in our state, and our country, treat diseases and to discover new forms of treatment, but they can also help keep Virginia’s economy moving forward.”

Round eight project winners, include:

Project Focus: Biofabrication of Regenerative Musculoskeletal Therapeutics

  • Company: Embody, LLC (Norfolk, VA)
  • University collaborators: Old Dominion University and University of Virginia
  • Funding amount: $800,000
  • Matching funds: $2,400,000 will be provided by Embody, LLC

Project Focus: Preventing Catheter Associated Infections

  • Company: WynnVision LLC (Richmond, VA)
  • University collaborators: Virginia Commonwealth University and University of Virginia
  • Funding amount: $510,000
  • Matching funds: $1,491,266 will be leveraged from a National Institutes of Health SBIR Phase II grant

Project Focus: Safe Mitochondrial Uncouplers for the Treatment of Human Disease

  • Company: Continuum Biosciences, Inc. (Blacksburg, VA)
  • University collaborators: Virginia Tech and University of Virginia
  • Funding amount: $400,000
  • Matching funds: $800,000 will be provided by Continuum Biosciences, Inc.

Project Focus: MRR: A Major New Chiral Analysis Technique for Drug Discovery, Development and Process Control

  • Company: BrightSpec, Inc. (Charlottesville, VA)
  • University collaborators: Virginia Commonwealth University, Virginia Tech and University of Virginia
  • Funding amount: $400,000
  • Matching funds: $400,000 will be provided by BrightSpec, Inc.

Project Focus: Novel Anti-inflammatory Drug with Strong Neuroprotective Properties for Treatment of Traumatic Brain Injury (TBI)

  • Company: Serpin Pharma (Manassas, VA)
  • University collaborators: Virginia Commonwealth University and George Mason University
  • Funding amount: $350,000
  • Matching funds: $350,000 will be provided by Serpin Pharma

Project Focus: Tissue Preparations for Therapeutic Use in Cardiovascular Applications

  • Company: LifeNet Health (Virginia Beach, VA)
  • University collaborators: Old Dominion University and Eastern Virginia Medical School
  • Funding amount: $250,000
  • Matching funds: $250,000 will be provided by LifeNet Health

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected